Please login to the form below

Not currently logged in
Email:
Password:

EMD Serono

This page shows the latest EMD Serono news and features for those working in and with pharma, biotech and healthcare.

EMD Serono allies with ‘free sequencing’ firm Nebula

EMD Serono allies with ‘free sequencing’ firm Nebula

Free genomic sequencing in exchange for data use. EMD Serono, the US pharma division of Merck KGaA, has formed an alliance with Nebula Genomics, a startup that offers free genome sequencing – ... Our collaboration with EMD Serono is the first

Latest news

  • Regeneron top science employer, says survey Regeneron top science employer, says survey

    20. -. Merck KGaA/Merck Serono/EMD Serono.  . Respondents indicated that being an innovation leader was the most important driver in choosing companies, but this year's survey also revealed that employees

  • This month in 1917: A tale of two Mercks This month in 1917: A tale of two Mercks

    E. Merck went on to assume the Merck KGaA name outside the US and Canada, as well as choosing to go by EMD (E. ... US and Canada, comprising the biopharma business EMD Serono and the life science tools business EMD Millipore.

  • Merck KGaA and Pfizer collaborate on lupus Merck KGaA and Pfizer collaborate on lupus

    Germany-based Merck KGaA – via its stateside subsidiary EMD Serono – and US-based Pfizer have signed an agreement with the Broad Institute, a non-profit research organisation affiliated with both the

  • FDA clears six new drugs in time for the new year FDA clears six new drugs in time for the new year

    The drug will compete in the US market with two other SBS treatments, namely EMD Serono's Zorbtive (somatropin) and Emmaus Medical's Nutrestore (glutamine). .

  • Digital Intelligence roundup

    Merck Serono has increased its digital outputs over the last few months, launching Twitter accounts for both its German operations and its EMD Serono US division in May. ... Meanwhile, EMD Serono has also joined the handful of pharmaceutical companies

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

  • The Medicines Company strengthens board of directors The Medicines Company strengthens board of directors

    Prior to joining ARIAD, Panayiotopoulos served as president of EMD Serono - the North American biopharmaceutical business of Merck KGaA - after serving as president of Merck Serono, Tokyo.

  • Former Novartis exec Richard Smith joins EMD Serono Former Novartis exec Richard Smith joins EMD Serono

    Merck KGaA's US biopharmaceutical business EMD Serono has appointed Richard Smith as senior vice president and head of US fertility and endocrinology. ... He joins EMD Serono from Novartis, where he spent the last 18 years in a series of roles across the

  • EMD Serono appoints neurology and immunology SVP EMD Serono appoints neurology and immunology SVP

    Millian most recently served as senior vice president and head of US fertility and endocrinology at EMD Serono, having first joined in 2010. ... Gary Zieziula, president and managing director of EMD Serono, said: “Craig is a dynamic leader with a

  • EMD Serono president James Hoyes joins consultants RxC EMD Serono president James Hoyes joins consultants RxC

    Hoyes subsequently held roles as executive vice president, managing EMD Serono's neurology sales, marketing, comms, call centre and medical affairs operations, and as chief commercial officer. ... Prior to joining EMD Serono, Hoyes held leadership

  • Merck appoints new North America and China biopharma leaders Merck appoints new North America and China biopharma leaders

    Zieziula (pictured right) has been appointed president and managing director for Merck's North American biopharma, EMD Serono, replacing Paris Panayiotopoulos with immediate effect.

More from appointments
Approximately 4 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics